Suntrust Banks’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$231K Sell
14,874
-18
-0.1% -$296 ﹤0.01% 1214
2019
Q2
$256K Buy
14,892
+399
+3% +$6.44K ﹤0.01% 1175
2019
Q1
$233K Buy
14,493
+902
+7% +$14.6K ﹤0.01% 1180
2018
Q4
$200K Sell
13,591
-6,505
-32% -$104K ﹤0.01% 1188
2018
Q3
$365K Sell
20,096
-506
-2% -$8.86K ﹤0.01% 1017
2018
Q2
$348K Buy
20,602
+8,019
+64% +$152K ﹤0.01% 1051
2018
Q1
$246K Sell
12,583
-299
-2% -$5.79K ﹤0.01% 1124
2017
Q4
$261K Sell
12,882
-1,224
-9% -$22.5K ﹤0.01% 1090
2017
Q3
$245K Sell
14,106
-514
-4% -$6.96K ﹤0.01% 1124
2017
Q2
$188K Buy
+14,620
New +$195K ﹤0.01% 1208

Other funds holding HALO

Suntrust Banks's HALO Position: Q3 2019 in Review

Suntrust Banks reduced its Halozyme (HALO) stake by 0.12% in Q3 2019, selling an estimated $296 and leaving 14,874 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1214.

Suntrust Banks first reported a position in HALO in Q2 2017 and has held it in 10 quarters since. The position peaked at $365K in Q3 2018. 210 funds tracked by Wall St. Rank hold HALO as of Q3 2019.

  • Suntrust Banks held 14,874 shares of Halozyme worth $231K as of Q3 2019.
  • Suntrust Banks sold 18 Halozyme shares in Q3 2019, an estimated $296.
  • Halozyme made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #1214 holding.
  • Suntrust Banks first reported a position in Halozyme in Q2 2017 and has held it in 10 quarters since.
  • Suntrust Banks's Halozyme position peaked at $365K in Q3 2018.
  • 210 funds tracked by Wall St. Rank held Halozyme as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.